you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Oct 14, 16:00
4959.70 28.40 (0.58%)
Volume
AVERAGE VOLUME
5-Day
66,016
10-Day
57,468
30-Day
49,754
28,053
  • Prev. Close

    4931.30

  • Open Price

    4934.00

  • Bid Price (Qty.)

    4938.00 (50)

  • Offer Price (Qty.)

    4949.00 (51)

NSE Live

Oct 14, 15:59
4958.70 30.25 (0.61%)
Volume
AVERAGE VOLUME
5-Day
371,104
10-Day
418,609
30-Day
438,463
292,060
  • Prev. Close

    4928.45

  • Open Price

    4924.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    4958.70 (278)

Financials

2020 2019 2018 2017 2016
Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) Mar 21 Mar 20 Mar 19 Mar 18 Mar 17  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 3,056.20 2,775.80 1,700.70 697.00 1,544.50  
Net CashFlow From Operating Activities 3,514.20 1,839.20 2,762.10 1,538.60 1,015.90  
Net Cash Used In Investing Activities -1,458.00 -1,689.20 -550.90 -1,179.90 1,442.50  
Net Cash Used From Financing Activities -794.30 -224.10 -2,223.10 -304.40 -2,581.80  
Foreign Exchange Gains / Losses 4.40 0.00 4.40 -0.30 -12.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 1,266.30 -74.10 -7.50 54.00 -135.40  
Cash And Cash Equivalents Begin of Year 39.10 113.20 120.70 66.70 202.10  
Cash And Cash Equivalents End Of Year 1,305.40 39.10 113.20 120.70 66.70  
Source : Dion Global Solutions Limited